5

Removal from labeling of 60-mg citalopram dose

Year:
2012
Language:
english
File:
PDF, 60 KB
english, 2012
7

Comorbid mood disorders and medical illness: a Food and Drug Administration perspective

Year:
2003
Language:
english
File:
PDF, 37 KB
english, 2003
8

Tolerance to the prolactin-elevating effect of neuroleptics

Year:
1981
Language:
english
File:
PDF, 400 KB
english, 1981
11

A Regulatory Perspective on Psychiatric Syndromes in Alzheimer Disease

Year:
2001
Language:
english
File:
PDF, 51 KB
english, 2001
13

Regulatory Issues in Pediatric Psychopharmacology

Year:
1996
Language:
english
File:
PDF, 6.05 MB
english, 1996
19

FDA Perspective on the DSM-5 Approach to Classification of “Cognitive” Disorders

Year:
2011
Language:
english
File:
PDF, 60 KB
english, 2011
22

Why Are Innovative Drugs Failing in Phase III?

Year:
2017
Language:
english
File:
PDF, 438 KB
english, 2017